Neoadjuvant Treatment in Locally Advanced Pancreatic Cancer (LAPC) Patients with FOLFIRINOX or Gemcitabine NabPaclitaxel: A Single-Center Experience and a Literature Review

The optimal therapeutic strategy for locally advanced pancreatic cancer patients (LAPC) has not yet been established. Our aim is to evaluate how surgery after neoadjuvant treatment with either FOLFIRINOX (FFN) or Gemcitabine-NabPaclitaxel (GemNab) affects the clinical outcome in these patients. LAPC...

Descripción completa

Detalles Bibliográficos
Autores principales: Napolitano, Fabiana, Formisano, Luigi, Giardino, Alessandro, Girelli, Roberto, Servetto, Alberto, Santaniello, Antonio, Foschini, Francesca, Marciano, Roberta, Mozzillo, Eleonora, Carratù, Anna Chiara, Cascetta, Priscilla, De Placido, Pietro, De Placido, Sabino, Bianco, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678351/
https://www.ncbi.nlm.nih.gov/pubmed/31337045
http://dx.doi.org/10.3390/cancers11070981

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678351/
https://www.ncbi.nlm.nih.gov/pubmed/31337045
http://dx.doi.org/10.3390/cancers11070981

Ejemplares similares